Morgan Stanley - Jun 30, 2025 SCHEDULE 13G Report for UroGen Pharma Ltd. Ordinary Shares (URGN)

Filing Manager: MORGAN STANLEY
Reporting Manager: Morgan Stanley
Security: UroGen Pharma Ltd. Ordinary Shares
Symbol: URGN
Shares outstanding: 46.1M shares
Disclosed Ownership: 2.49M shares
Ownership: 5.4%
Form type: SCHEDULE 13G
Date filed: 8/6/2025, 03:56 PM
Date of event: Jun 30, 2025
Previous filing: Feb 5, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Morgan Stanley	5.4%	2.49M	0	2.46M	Chris O'Hara	Authorized Signatory, Morgan Stanley